Join HJF and ATCC for an exclusive forum bringing together investors, entrepreneurs, and innovators at the forefront of antimicrobial resistance (AMR). This event will explore emerging investment opportunities in one of the world's most pressing health challenges while highlighting the critical role that high-quality biological resources, authenticated microbial strains, genomic datasets, reference standards, and AI-ready biological data play in accelerating innovation. Through expert discussions, investor insights, and a 'start-up to scale-up' spotlight session, attendees will gain a deeper understanding of how to de-risk development, strengthen regulatory readiness, and fast-track the commercialization of next-generation AMR solutions.
Countdown to the Event
- Days17161716
- Hours24232423
- Minutes7676
